Table 4.
Studies on the use of BoNT-A therapy in pompholyx.
First Author [Ref.], year | Type of Study | n | BoNT-A Doses/Hand | Follow-Up | Retreatment | Results |
---|---|---|---|---|---|---|
Ismail [102], 2020 | Prospective non-randomized side-by-side comparative study | 40 | 100 | 1, 4, 6 months | No | Improvement |
Kontochristopoulos [101], 2007 | Case reports | 2 | 4.0 mL saline in 100 U BoNT-A; 100 U/hand | 8 weeks | No | Improvement |
Swartling [96], 2002 | Prospective | 10 | 1.0 mL saline in 100 U BoNT-A; mean of 162 U/hand | 28–59 days | No | 7 of 10 patients reported a good result; improving in VAS for itching and disease activity score |
Wollina [100], 2002 | Prospective; side-by-side monotherapy with topical steroid vs. adjuvant BoNT-A injection | 6 | 2.0 mL saline in 100 U BoNT-A | 8 weeks | No | Six of 6 hands treated with topical steroids in combination with BoNT-A showed improvement; BoNT-A showed a more rapid release from itching than steroids alone |